Literature DB >> 22034112

Effectiveness of dexamethasone iontophoresis for temporomandibular joint involvement in juvenile idiopathic arthritis.

Rina Mina1, Paula Melson, Stephanie Powell, Marepalli Rao, Claas Hinze, Murray Passo, T Brent Graham, Hermine I Brunner.   

Abstract

OBJECTIVE: Temporomandibular joint (TMJ) involvement is common in juvenile idiopathic arthritis (JIA). Dexamethasone iontophoresis (DIP) uses low-grade electric currents for transdermal dexamethasone delivery into deeper anatomic structures. The purpose of this study was to assess the safety and effectiveness of DIP for the treatment of TMJ involvement in JIA, and to delineate variables that are associated with improvement after DIP.
METHODS: Medical records of all JIA patients who underwent DIP for TMJ involvement at a larger tertiary pediatric rheumatology center from 1997-2011 were reviewed. DIP was performed using a standard protocol. The effectiveness of DIP was assessed by comparing the maximal interincisor opening (MIO(TMJ) ) and the maximal lateral excursion (MLE(TMJ) ) before and after treatment.
RESULTS: Twenty-eight patients (ages 2-21 years) who received an average of 8 DIP treatment sessions per involved TMJ were included in the analysis. Statistically significant improvement in the median MIO(TMJ) (P < 0.0001) was observed in 68%. The median MLE(TMJ) (P = 0.03) improved in 69%, and resolution of TMJ pain occurred in 73% of the patients who had TMJ pain at baseline. Side effects of DIP were transient site erythema (86%), skin blister (4%), and metallic taste (4%). Improvement in TMJ range of motion from DIP is associated with lower MIO(TMJ) , lower MLE(TMJ) , and absence of TMJ crepitus at baseline.
CONCLUSION: In this pilot study, DIP appeared to be an effective and safe initial treatment of TMJ involvement in JIA, especially among patients with decreased TMJ measurements. Prospective controlled studies are needed.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22034112      PMCID: PMC3204193          DOI: 10.1002/acr.20600

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  29 in total

Review 1.  The prospective use of COX-2 inhibitors for the treatment of temporomandibular joint inflammatory disorders.

Authors:  C A Kerins; R Spears; L L Bellinger; B Hutchins
Journal:  Int J Immunopathol Pharmacol       Date:  2003 May-Aug       Impact factor: 3.219

2.  Iontophoresis: an effective modality for the treatment of inflammatory disorders of the temporomandibular joint and myofascial pain.

Authors:  M R Lark; L P Gangarosa
Journal:  Cranio       Date:  1990-04       Impact factor: 2.020

Review 3.  Topical agents in the treatment of rheumatic disorders.

Authors:  E D Rosenstein
Journal:  Rheum Dis Clin North Am       Date:  1999-11       Impact factor: 2.670

4.  The quantity and distribution of radiolabeled dexamethasone delivered to tissue by iontophoresis.

Authors:  J M Glass; R L Stephen; S C Jacobson
Journal:  Int J Dermatol       Date:  1980-11       Impact factor: 2.736

5.  Interobserver variability in assessment of signs of TMD.

Authors:  M T John; A J Zwijnenburg
Journal:  Int J Prosthodont       Date:  2001 May-Jun       Impact factor: 1.681

6.  Effect of methotrexate on the temporomandibular joint and facial morphology in juvenile rheumatoid arthritis patients.

Authors:  D O Ince; A Ince; T L Moore
Journal:  Am J Orthod Dentofacial Orthop       Date:  2000-07       Impact factor: 2.650

7.  Temporomandibular joint involvement in children with juvenile idiopathic arthritis.

Authors:  Elvira Cannizzaro; Silke Schroeder; Lukas M Müller; Christian J Kellenberger; Rotraud K Saurenmann
Journal:  J Rheumatol       Date:  2010-12-15       Impact factor: 4.666

8.  Discriminant validity of temporomandibular joint range of motion measurements obtained with a ruler.

Authors:  N Walker; R W Bohannon; D Cameron
Journal:  J Orthop Sports Phys Ther       Date:  2000-08       Impact factor: 4.751

9.  Temporomandibular involvement in juvenile idiopathic arthritis.

Authors:  Marinka Twilt; Shell M L M Mobers; Lidia R Arends; Rebecca ten Cate; Lisette van Suijlekom-Smit
Journal:  J Rheumatol       Date:  2004-07       Impact factor: 4.666

10.  Temporomandibular joint involvement in juvenile rheumatoid arthritis. Clinical diagnostic criteria.

Authors:  A E Stabrun; T A Larheim; H M Høyeraal
Journal:  Scand J Rheumatol       Date:  1989       Impact factor: 3.641

View more
  9 in total

Review 1.  Trials and tribulations of skin iontophoresis in therapeutics.

Authors:  Matthieu Roustit; Sophie Blaise; Jean-Luc Cracowski
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

Review 2.  Assessment and management of pain in juvenile idiopathic arthritis.

Authors:  Jennifer E Weiss; Nadia J C Luca; Alexis Boneparth; Jennifer Stinson
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

Review 3.  Temporomandibular disorders. Part 2: conservative management.

Authors:  Stephen M Shaffer; Jean-Michel Brismée; Phillip S Sizer; Carol A Courtney
Journal:  J Man Manip Ther       Date:  2014-02

Review 4.  Pharmacological treatment of chronic non-cancer pain in pediatric patients.

Authors:  Eapen Mathew; Eugene Kim; Kenneth R Goldschneider
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

5.  Corticosteroid transdermal delivery significantly improves arthritis pain and functional disability.

Authors:  Tommaso Iannitti; Michael F McDermott; Carmen Laurino; Andrea Malagoli; Beniamino Palmieri
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

6.  Effect of dexamethasone prodrug on inflamed temporomandibular joints in juvenile rats.

Authors:  Mitchell Knudsen; Matthew Bury; Callie Holwegner; Adam L Reinhardt; Fang Yuan; Yijia Zhang; Peter Giannini; David B Marx; Dong Wang; Richard A Reinhardt
Journal:  Arthritis Res Ther       Date:  2015-09-24       Impact factor: 5.156

7.  Delivery of neostigmine and glycopyrrolate by iontophoresis: a nonrandomized study in individuals with spinal cord injury.

Authors:  Mark A Korsten; Brian L Lyons; Miroslav Radulovic; Tradd M Cummings; Gautam Sikka; Kamaldeep Singh; Joshua C Hobson; Anton Sabiev; Ann M Spungen; William A Bauman
Journal:  Spinal Cord       Date:  2017-11-08       Impact factor: 2.772

Review 8.  Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what?

Authors:  Matthew L Stoll; Chung H Kau; Peter D Waite; Randy Q Cron
Journal:  Pediatr Rheumatol Online J       Date:  2018-04-25       Impact factor: 3.054

Review 9.  Selected Medicines Used in Iontophoresis.

Authors:  Tomasz M Karpiński
Journal:  Pharmaceutics       Date:  2018-10-25       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.